Vaginal carrier for the controlled release of substances

Abstract

A device that delivers one or more substances into a vaginal lumen according to one of a plurality of release patterns. The device comprises a supporting structure, substance dispensers, and / or coupling elements which are configured to release one or more substances, for example, drugs, in manner designed to optimize treatment of one or more medical conditions.

Description

RELATED APPLICATIONS[0001]This application is a continuation of U.S. patent application Ser. No. 12 / 921,158 filed on Sep. 6, 2010, which is a National Phase of PCT Patent Application No. PCT / IL2009 / 000240 having International filing date of Mar. 2, 2009, which claims the benefit of U.S. Provisional Patent Application No. 61 / 064,394 filed on Mar. 4, 2008.[0002]The contents of the above applications are all incorporated by reference as if fully set forth herein in their entirety.FIELD AND BACKGROUND OF THE INVENTION[0003]The present invention, in some embodiments thereof, relates to medical devices and, more particularly, but not exclusively, to controlled delivery of therapeutic agents, in humans and in animal species.[0004]Presently, most medications are consumed via several routes, mainly orally. Oral ingestion of most drugs is followed by inactivation of a large portion of those drugs while passing through the liver, and the rest of the drugs enter the blood stream in a surge, wit...

AI Technical Summary

Benefits of technology

The coupling described in this patent allows for the placement of a supporting structure and substance dispenser around the edges of the vaginal lumen, without taking up the center and interfering with the sexual experience.

Problems solved by technology

Most of the known drug delivery systems to the vagina have severe drawbacks such as leakage of the drug (as with creams, gels, and melted pessaries), limited residence time of the formulation on the vaginal wall due to gravity, motion, and poor adherence capacity of the drug or its carrier, the presence of menstrual cycle, local irritation by some of the drug carriers (tablets or pessaries), and personal care habits.

In some cases, the vaginal normal flora, mainly the Lactobacilus Acidophilus, may be damaged, giving rise to abnormal flora.

Some of these medications are designed be inserted manually by the user, a procedure not always welcome by all women.

The affect of the drug is usually during a short period, and there is no way to stop it once applied into the vagina.

Also, only a relatively small number of medications may be utilized by this route, without the ability to target a specific vaginal wall or adjacent organ.

As a ring, it is impossible to direct the drug towards a specific organ, such as the bladder or uterus, hence the inability to affect a specific pelvic organ.

Also, as a solid ring it is difficult to supply various drugs on the same carrier.

This complicated method may allow for more than one drug to be incorporated into a ring controlled release drug carrier.

Images